Combining cross-sectional survey and register data improved the estimate of hepatitis C prevalence among patients attending a psychiatric emergency department in Denmark

References

• Blach S, Terrault NA, Tacke F, et al. Global change in hepatitis C virus prevalence and Cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022;7(5):396–415. doi: 10.1016/S2468-1253(21)00472-6.
   PubMed Web of Science ®Google Scholar
• World Health O. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. Geneva: World Health Organization; 2016. Contract No.: WHO/HIV/2016.06.
   Google Scholar
• Dröse S, Øvrehus ALH, Holm DK, et al. A multi-level intervention to eliminate hepatitis C from the region of Southern Denmark: the C-Free-South project. BMC Infect Dis. 2022;22(1):202. doi: 10.1186/s12879-022-07196-7.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Hansen JF, Hay G, et al. Hepatitis C prevalence in Denmark in 2016 - an updated estimate using multiple national registers. PLoS One. 2020;15(9):e0238203. doi: 10.1371/journal.pone.0238203.
   PubMed Web of Science ®Google Scholar
• Howell J, Traeger MW, Williams B, et al. The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: an Australian pilot study. J Viral Hepat. 2022;29(5):375–384. doi: 10.1111/jvh.13664.
   PubMed Web of Science ®Google Scholar
• Braude MR, Phan T, Dev A, et al. Determinants of hepatitis C virus prevalence in people With serious mental illness: a systematic review and meta-analysis. J Clin Psychiatry. 2021;83(1):21r14079. doi: 10.4088/JCP.21r14079.
   PubMed Web of Science ®Google Scholar
• Hughes E, Bassi S, Gilbody S, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(1):40–48. doi: 10.1016/S2215-0366(15)00357-0.
   PubMed Web of Science ®Google Scholar
• Bauer-Staeb C, Jörgensen L, Lewis G, et al. Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden. Lancet Psychiatry. 2017;4(9):685–693. doi: 10.1016/S2215-0366(17)30253-5.
   PubMed Web of Science ®Google Scholar
• Awan A, Shakik S, Banack HR, et al. Hepatitis B and C in individuals with a history of antipsychotic medication use: a population-based evaluation. PLoS One. 2023;18(4):e0284323. doi: 10.1371/journal.pone.0284323.
   PubMed Web of Science ®Google Scholar
• Blackwell JA, Rodgers JB, Franco RA, et al. Predictors of linkage to care for a nontargeted emergency department hepatitis C screening program. Am J Emerg Med. 2020;38(7):1396–1401. doi: 10.1016/j.ajem.2019.11.034.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Wahlbeck K, Hällgren J, et al. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the nordic countries. PLoS One. 2013;8(6):e67133. doi: 10.1371/journal.pone.0067133.
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Wahlbeck K, Hällgren J, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One. 2013;8(1):e55176. doi: 10.1371/journal.pone.0055176.
   PubMed Web of Science ®Google Scholar
• Turpeinen P, Leinikki P, Seppälä T, et al. Drug abuse and viral hepatitis among psychiatric admissions to a finnish psychiatric emergency ward. Nordic J Psychiatry. 1999;53(2):141–145. doi: 10.1080/080394899426855.
   Web of Science ®Google Scholar
• Øvrehus A. Towards elimination of heptitis C. Syddansk Universitet. Odense, Denmark: Faculty of Health Sciences, University of Southern Denmark; 2019.
   Google Scholar
• WHO. WHO prequalification of In vitro diagnostics. PUBLIC REPORT Product: Rapid Anti‐HCV Test Geneva; 2019. Report No.: PQDx 0371-017-00. Geneva, Switzerland: WHO, Regulation and Prequalification Department.
   Google Scholar
• InTec. Rapid anti-HCV test. 2022. Available from: https://www.intecasi.com/rapid-anti-hcv-test_p10.html.
   Google Scholar
• Gupta E, Bajpai M, Choudhary A. Hepatitis C virus: screening, diagnosis, and interpretation of laboratory assays. Asian J Transfus Sci. 2014;8(1):19–25. doi: 10.4103/0973-6247.126683.
   PubMedGoogle Scholar
• Mössner BK, Staugaard B, Jensen J, et al. Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life. World J Gastroenterol. 2016;22(33):7604–7612. doi: 10.3748/wjg.v22.i33.7604.
   PubMed Web of Science ®Google Scholar
• Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev. 1995;17(2):243–264. doi: 10.1093/oxfordjournals.epirev.a036192.
   PubMed Web of Science ®Google Scholar
• Wentworth JJ, Øvrehus ALH, Hansen JF, et al. Emergency department testing is feasible but ineffective to eliminate hepatitis C in Denmark. Infect Dis (Lond). 2021;53(12):930–941. doi: 10.1080/23744235.2021.1962542.
   PubMed Web of Science ®Google Scholar
• Grebely J, Larney S, Peacock A, et al. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction. 2019;114(1):150–166. doi: 10.1111/add.14393.
   PubMed Web of Science ®Google Scholar
• Øvrehus A, Nielsen S, Hansen JF, et al. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study. Addiction. 2019;114(3):494–503. doi: 10.1111/add.14479.
   PubMed Web of Science ®Google Scholar
• Sharafi H, Poustchi H, Azimian F, et al. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting. J Clin Virol. 2019;113:20–23. doi: 10.1016/j.jcv.2019.02.005.
   PubMed Web of Science ®Google Scholar
• Toyoda H, Kumada T, Kiriyama S, et al. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy. Clin Infect Dis. 2005;40(6):e49-54–e54. doi: 10.1086/428128.
   PubMed Web of Science ®Google Scholar
• Girardin F, Painter C, Hearmon N, et al. Hepatitis C prevalences in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy. JHEP Rep. 2021;3(3):100279. doi: 10.1016/j.jhepr.2021.100279.
   PubMedGoogle Scholar
• Yip TC, Wong GL, Tse YK, et al. High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study. BMC Gastroenterol. 2020;20(1):128. doi: 10.1186/s12876-020-01277-0.
   PubMed Web of Science ®Google Scholar
• Pelto-Piri V, Engström K, Engström I. Paternalism, autonomy and reciprocity: ethical perspectives in encounters with patients in psychiatric in-patient care. BMC Med Ethics. 2013;14(1):49. doi: 10.1186/1472-6939-14-49.
   PubMedGoogle Scholar
• SSI. Hepatitis C 2019-2020 – acute and chronic. 2021. Available from: https://en.ssi.dk/surveillance-and-preparedness/surveillance-in-denmark/annual-reports-on-disease-incidence/hepatitis-c-2019-2020–-acute-and-chronic
   Google Scholar
• Dröse S, Hansen JF, Røge BT, et al. Retrieval of patients with hepatitis C who were lost to follow-up in Southern Denmark. Infect Dis (Lond). 2023;55(5):361–369. doi: 10.1080/23744235.2023.2189298.
   PubMed Web of Science ®Google Scholar